Personalized Medicine and Osteoporosis to Be Featured

Glenn M. Chertow, MD, MPH

/kidneynews/12_10_11/38a/graphic/38af1.jpg

A researcher with a broad portfolio will provide the “Rationale for Personalized Medicine Approaches to the Management of CKD-Associated Osteoporosis” in the Jack W. Coburn, MD, Endowed Lectureship on Friday, Oct. 23.

The speaker will be Glenn M. Chertow, MD, MPH, who is the Norman S. Coplon Satellite Healthcare Professor of Medicine and chief of the division of nephrology at Stanford University School of Medicine.

In addition to teaching, mentoring, and maintaining an active clinical practice, Dr. Chertow has carried out a robust clinical research program centered on clinical epidemiology, health-services research, decision science, and clinical trials in acute and chronic kidney disease. He has been the author or co-author of more than 500 peer-reviewed manuscripts shedding light on AKI, CKD, ESKD, and associated complications, including those related to bone and mineral metabolism, cardiovascular disease, and nutrition.

He has served in leadership roles for multiple clinical trials sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute; Veterans Administration; and industry. Recent projects for NIDDK include work on the Acute Renal Failure Trials Network Study, the U.S. Renal Data System Special Studies Center in Nutrition, the Chronic Renal Insufficiency Cohort Study, and the Frequent Hemodialysis Network Study.

Dr. Chertow has served in an advisory capacity to the Medicare Payment Advisory Committee and the National Quality Forum on issues related to the ESKD program as well as on National Institutes of Health study sections. He was vice chair and member of two workgroups for the Kidney Disease Outcomes Quality Initiative (K/DOQI). He has served ASN in many roles, including on the public policy board, on the quality metrics taskforce, and as associate editor of JASN. He is co-editor of Brenner and Rector’s The Kidney.

He received the Belding H. Scribner Award from ASN, the National Torchbearer Award and Nephrologist of the Year Award from the American Kidney Fund, and the David M. Hume Memorial Award from the National Kidney Foundation. He has been elected to the Association of American Physicians, National Academy of Medicine, and American Society of Clinical Investigation.

Dr. Chertow received his medical degree from Harvard Medical School and his master of public health in epidemiology and biostatistics from the Harvard School of Public Health. He completed his residency in internal medicine and fellowship in nephrology at Brigham and Women’s Hospital in Boston before joining the Harvard faculty, where he remained until 1998. He then joined the faculty at the University of California, San Francisco, where he served as director of clinical services in the division of nephrology. He was promoted through the academic ranks to full professor in the department of medicine and the department of epidemiology and biostatistics. He joined the Stanford faculty in 2007.

October-November 2020 (Vol. 12, Number 10 & 11)